BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

413 related articles for article (PubMed ID: 32127125)

  • 1. Authors' response: Plenty of coronaviruses but no SARS-CoV-2.
    Reusken CB; Haagmans B; Meijer A; Corman VM; Papa A; Charrel R; Drosten C; Koopmans M
    Euro Surveill; 2020 Feb; 25(8):. PubMed ID: 32127125
    [No Abstract]   [Full Text] [Related]  

  • 2. Genome Composition and Divergence of the Novel Coronavirus (2019-nCoV) Originating in China.
    Wu A; Peng Y; Huang B; Ding X; Wang X; Niu P; Meng J; Zhu Z; Zhang Z; Wang J; Sheng J; Quan L; Xia Z; Tan W; Cheng G; Jiang T
    Cell Host Microbe; 2020 Mar; 27(3):325-328. PubMed ID: 32035028
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Asymptomatic coronavirus infection: MERS-CoV and SARS-CoV-2 (COVID-19).
    Al-Tawfiq JA
    Travel Med Infect Dis; 2020; 35():101608. PubMed ID: 32114075
    [No Abstract]   [Full Text] [Related]  

  • 4. Molecular Basis of Pathogenesis of Coronaviruses: A Comparative Genomics Approach to Planetary Health to Prevent Zoonotic Outbreaks in the 21st Century.
    Asrani P; Hasan GM; Sohal SS; Hassan MI
    OMICS; 2020 Nov; 24(11):634-644. PubMed ID: 32940573
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Innate Immune Responses to Highly Pathogenic Coronaviruses and Other Significant Respiratory Viral Infections.
    Ahmed-Hassan H; Sisson B; Shukla RK; Wijewantha Y; Funderburg NT; Li Z; Hayes D; Demberg T; Liyanage NPM
    Front Immunol; 2020; 11():1979. PubMed ID: 32973803
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Coronavirus Disease 2019: Coronaviruses and Blood Safety.
    Chang L; Yan Y; Wang L
    Transfus Med Rev; 2020 Apr; 34(2):75-80. PubMed ID: 32107119
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serologic testing of coronaviruses from MERS-CoV to SARS-CoV-2: Learning from the past and anticipating the future.
    Al-Tawfiq JA; Memish ZA
    Travel Med Infect Dis; 2020; 37():101785. PubMed ID: 32534208
    [No Abstract]   [Full Text] [Related]  

  • 8. SARS-CoV, Mers-CoV and COVID-19: what differences from a dermatological viewpoint?
    Rongioletti F
    J Eur Acad Dermatol Venereol; 2020 Oct; 34(10):e581-e582. PubMed ID: 32526085
    [No Abstract]   [Full Text] [Related]  

  • 9. Viral loads of SARS-CoV, MERS-CoV and SARS-CoV-2 in respiratory specimens: What have we learned?
    Al-Tawfiq JA
    Travel Med Infect Dis; 2020; 34():101629. PubMed ID: 32179122
    [No Abstract]   [Full Text] [Related]  

  • 10. [Coronavirus, emerging viruses].
    Juckel D; Dubuisson J; Belouzard S
    Med Sci (Paris); 2020; 36(6-7):633-641. PubMed ID: 32558641
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Emerging coronaviruses: first SARS, second MERS and third SARS-CoV-2: epidemiological updates of COVID-19.
    Halaji M; Farahani A; Ranjbar R; Heiat M; Dehkordi FS
    Infez Med; 2020 Jun; 28(suppl 1):6-17. PubMed ID: 32532933
    [TBL] [Abstract][Full Text] [Related]  

  • 12. From SARS and MERS CoVs to SARS-CoV-2: Moving toward more biased codon usage in viral structural and nonstructural genes.
    Kandeel M; Ibrahim A; Fayez M; Al-Nazawi M
    J Med Virol; 2020 Jun; 92(6):660-666. PubMed ID: 32159237
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Diagnosis, treatment, control and prevention of SARS-CoV-2 and coronavirus disease 2019: back to the future].
    Ye ZW; Jin DY
    Sheng Wu Gong Cheng Xue Bao; 2020 Apr; 36(4):571-592. PubMed ID: 32347053
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of the severe acute respiratory syndrome coronavirus (SARS-CoV) and the Middle East respiratory syndrome coronavirus (MERS-CoV) on the nervous system. What can we expect from SARS -CoV-2?
    Monroy-Gómez J; Torres-Fernández O
    Biomedica; 2020 Oct; 40(Supl. 2):173-179. PubMed ID: 33152201
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Escaping Pandora's Box - Another Novel Coronavirus.
    Morens DM; Daszak P; Taubenberger JK
    N Engl J Med; 2020 Apr; 382(14):1293-1295. PubMed ID: 32101660
    [No Abstract]   [Full Text] [Related]  

  • 16. [Strategies for vaccine development of COVID-19].
    Yang L; Tian D; Liu W
    Sheng Wu Gong Cheng Xue Bao; 2020 Apr; 36(4):593-604. PubMed ID: 32347054
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Coronavirus discovery by metagenomic sequencing: a tool for pandemic preparedness.
    Carbo EC; Sidorov IA; Zevenhoven-Dobbe JC; Snijder EJ; Claas EC; Laros JFJ; Kroes ACM; de Vries JJC
    J Clin Virol; 2020 Oct; 131():104594. PubMed ID: 32866812
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A Comprehensive Review of Manifestations of Novel Coronaviruses in the Context of Deadly COVID-19 Global Pandemic.
    Gulati A; Pomeranz C; Qamar Z; Thomas S; Frisch D; George G; Summer R; DeSimone J; Sundaram B
    Am J Med Sci; 2020 Jul; 360(1):5-34. PubMed ID: 32620220
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Overlapping and discrete aspects of the pathology and pathogenesis of the emerging human pathogenic coronaviruses SARS-CoV, MERS-CoV, and 2019-nCoV.
    Liu J; Zheng X; Tong Q; Li W; Wang B; Sutter K; Trilling M; Lu M; Dittmer U; Yang D
    J Med Virol; 2020 May; 92(5):491-494. PubMed ID: 32056249
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Coronaviruses: An Updated Overview of Their Replication and Pathogenesis.
    Wang Y; Grunewald M; Perlman S
    Methods Mol Biol; 2020; 2203():1-29. PubMed ID: 32833200
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.